WHO Declares An End To Swine Flu Pandemic, But Says A Second Wave Is Possible
This article was originally published in The Pink Sheet Daily
Sales of pandemic flu vaccines and Tamiflu will decline steeply; seasonal flu vaccines for the 2010-11 northern hemisphere flu season will contain H1N1 as one of their three antigens.
You may also be interested in...
Inovio Pharmaceuticals has reported promising initial data from its first Phase III study of its electrical current-driven DNA plasmid-based immunotherapy, VGX-3100, in virus-associated cervical dysplasia; it is heading a small group of companies evaluating novel therapies in the condition, which often advances to cancer.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Two European pharmaceutical companies, UCB and Merck KGaA, are exploring artificial intelligence in different ways, the first for drug discovery and the second on a fundamental level.